This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Victor Beaumont, PhD
Strategic Market Development Specialist at Bruker UK Limited
Speaker

Profile

Victor received his Bachelor’s degree from SUNY University of Buffalo and his PhD from Yale University in chemistry focused on high-resolution protein structure characterization. His career in the pharmaceutical industry was dedicated to innovative structure characterization of biological and later in lab automation. At Bruker, Victor engages with various pharmaceutical leaders to collaborate on innovative technology, methods, and applications to drive better therapeutic safety, efficacy, and quality for improved patient wellbeing.

Agenda Sessions

  • Decoding the Structures of Peptides and Oligonucleotides through Innovative Technology

    12:15